BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38241051)

  • 1. Progress Toward Cardiac Risk Reduction With the Evolution of Pediatric Hodgkin Lymphoma Therapy.
    Leger KJ; Narayan HK
    JAMA Netw Open; 2024 Jan; 7(1):e2350999. PubMed ID: 38241051
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma.
    McKay P; Fielding P; Gallop-Evans E; Hall GW; Lambert J; Leach M; Marafioti T; McNamara C;
    Br J Haematol; 2016 Jan; 172(1):32-43. PubMed ID: 26538004
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving Care for All Pediatric Patients With Hodgkin Lymphoma.
    Flerlage JE
    J Natl Compr Canc Netw; 2021 Jun; 19(6):771-772. PubMed ID: 34214974
    [No Abstract]   [Full Text] [Related]  

  • 4. Pediatric Hodgkin Lymphoma, Version 3.2021.
    Flerlage JE; Hiniker SM; Armenian S; Benya EC; Bobbey AJ; Chang V; Cooper S; Coulter DW; Cuglievan B; Hoppe BS; Isenalumhe L; Kelly K; Kersun L; Lamble AJ; Larrier NA; Magee J; Oduro K; Pacheco M; Price AP; Roberts KB; Smith CM; Sohani AR; Trovillion EM; Walling E; Xavier AC; Burns JL; Campbell M
    J Natl Compr Canc Netw; 2021 Jun; 19(6):733-754. PubMed ID: 34214968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL).
    Wyatt KD; Birz S; Castellino SM; Henderson TO; Lucas JT; Pei Q; Zhou Y; Volchenboum SL; Furner B; Watkins M; Kelly KM; Flerlage JE;
    J Natl Cancer Inst; 2024 May; 116(5):642-646. PubMed ID: 38273668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is this the end of radiotherapy in early hodgkin lymphoma?
    Maund IF; Williams MV; Hoskin PJ; Follows GA
    Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):46-8. PubMed ID: 22841148
    [No Abstract]   [Full Text] [Related]  

  • 7. Workshop on pediatric lymphomas: current results and prospects.
    Murphy SB; Magrath IT
    Ann Oncol; 1991 Feb; 2 Suppl 2():219-23. PubMed ID: 1675584
    [No Abstract]   [Full Text] [Related]  

  • 8. Current approaches to the management of pediatric Hodgkin lymphoma.
    Freed J; Kelly KM
    Paediatr Drugs; 2010 Apr; 12(2):85-98. PubMed ID: 20218745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited-Stage Hodgkin Lymphoma: Minimizing Toxicity.
    Straus DJ
    Cancer J; 2018; 24(5):223-229. PubMed ID: 30247257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment strategies for pediatric nodular lymphocyte predominant Hodgkin's lymphoma.
    Vassilakopoulos TP; Angelopoulou MK; Pangalis GA
    Leuk Lymphoma; 2006 Aug; 47(8):1450-1. PubMed ID: 16966251
    [No Abstract]   [Full Text] [Related]  

  • 11. I. Hodgkin lymphoma: special challenges and solutions.
    Connors JM
    Hematol Oncol; 2015 Jun; 33 Suppl 1():21-4. PubMed ID: 26062048
    [No Abstract]   [Full Text] [Related]  

  • 12. A rare case of primary cardiac Hodgkin lymphoma in a child.
    Zoma JM; Aggarwal S; Gabali A; Kobayashi D
    Cardiol Young; 2020 Jun; 30(6):866-868. PubMed ID: 32513336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.
    McCarten KM; Nadel HR; Shulkin BL; Cho SY
    Pediatr Radiol; 2019 Oct; 49(11):1545-1564. PubMed ID: 31620854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual sequence of lymphoid disorders: follicular lymphoma subsequent to Hodgkin lymphoma and transformed into diffuse large B-cells non Hodgkin lymphoma.
    Niscola P; Palombi M; Fratoni S; Trawinska MM; Scaramucci L; Giovannini M; Perrotti A; De Fabritiis P
    Acta Oncol; 2009; 48(7):1073-4. PubMed ID: 19308758
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary orbital manifestation of Hodgkin lymphoma in a 3-year-old child.
    Harrison AR; Mokhtarzadeh A; Melicher Larson JS; Dewan MA; Lee MS
    Ophthalmic Plast Reconstr Surg; 2010; 26(6):494-6. PubMed ID: 20859240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report.
    Trippett TM; Schwartz CL; Guillerman RP; Gamis AS; Gardner S; Hogan S; London WB; Chen L; de Alarcon P
    Pediatr Blood Cancer; 2015 Jan; 62(1):60-4. PubMed ID: 25308760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.
    Advani RH; Hoppe RT
    Hematol Oncol; 2015 Jun; 33 Suppl 1():90-5. PubMed ID: 26062064
    [No Abstract]   [Full Text] [Related]  

  • 18. [Malignant lymphoma in pediatrics].
    Ise T
    Rinsho Hoshasen; 1985 Oct; 30(11):1415-25. PubMed ID: 3910879
    [No Abstract]   [Full Text] [Related]  

  • 19. Hodgkin disease/lymphoma.
    Hoppe RT; Advani RH; Ambinder RF; Bierman PJ; Bloomfield CD; Blum K; Dabaja B; Djulbegovic B; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hudson MM; Kaminski MS; Love G; Maloney DG; Mansur D; Mauch PM; Moore JO; Schilder RJ; Weiss LM; Winter JN; Yahalom J; Zelenetz AD;
    J Natl Compr Canc Netw; 2008 Jul; 6(6):594-622. PubMed ID: 18597713
    [No Abstract]   [Full Text] [Related]  

  • 20. Childhood Hodgkin and non-Hodgkin lymphomas.
    Leventhal BG; Kato GJ
    Pediatr Rev; 1990 Dec; 12(6):171-9. PubMed ID: 2287598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.